streptococc
pharyng
common
patholog
paediatr
age
world
nevertheless
nt
joint
agreement
manag
condit
author
recommend
perform
microbiolog
investig
suspect
bacteri
case
order
treat
confirm
case
antibiot
prevent
suppur
complic
acut
rheumat
fever
differ
author
consid
pharyng
even
streptococc
one
benign
selflimit
diseas
consequ
would
nt
routin
perform
microbiolog
test
point
judici
use
antibiot
would
reserv
antimicrobi
treatment
wellselect
case
calcul
number
patient
need
treat
prevent
one
complic
upper
respiratori
tract
infect
includ
sore
throat
even
use
centor
score
order
evalu
risk
streptococc
infect
debat
interpret
test
result
may
vari
consider
penicillin
consid
world
first
line
treatment
oral
amoxicillin
also
accept
due
better
palat
suitabl
option
macrolid
reserv
rare
case
prove
allergi
cephalosporin
use
patient
allerg
penicillin
except
type
hypersens
also
propos
treat
relaps
acut
pharyng
defin
infect
pharynx
andor
tonsil
common
patholog
among
children
adolesc
although
virus
caus
acut
pharyng
episod
group
streptococcu
gabh
caus
case
acut
pharyng
children
older
year
bacteri
caus
pharyng
group
c
streptococcu
total
case
c
pneumonia
pneumonia
anaerob
speci
virus
rhinoviru
coronaviru
adenoviru
account
total
case
epstein
barr
viru
influenza
parainfluenza
viru
streptococc
pharyng
peak
incid
earli
school
year
uncommon
year
age
ill
occur
often
winter
spring
infect
transmit
via
respiratori
secret
incub
period
day
communic
infect
highest
acut
phase
untreat
peopl
gradual
diminish
period
week
ceas
hour
antibiot
therapi
clinic
manifest
includ
sore
throat
fever
sudden
onset
red
pharynx
enlarg
tonsil
cover
yellow
bloodting
exud
may
petechia
soft
palat
posterior
pharynx
anterior
cervic
node
enlarg
swollen
headach
gastrointestin
symptom
vomit
abdomin
pain
frequent
tabl
show
sign
symptom
gabh
pharyng
sensit
specif
diagnosi
onset
viral
pharyng
may
gradual
symptom
often
includ
rhinorrhea
cough
diarrhea
hoars
sever
clinic
score
propos
help
clinician
diagnosi
illustr
tabl
anyway
clinic
present
gabh
viral
pharyng
show
consider
overlap
singl
element
patient
histori
physic
examin
reliabl
confirm
exclud
gabh
pharyng
complic
infect
distinguish
suppur
nonsuppur
suppur
complic
due
spread
gabh
adjac
tissu
includ
cervic
lymphaden
peritonsillar
abscess
retropharyng
abscess
otiti
media
mastoid
sinus
use
antibiot
reduc
incid
group
complic
remain
realiti
primari
ill
gone
unnot
untreat
suppur
immunemedi
sequela
acut
rheumat
fever
arf
acut
poststreptococc
glomerulonephr
sydenham
chorea
reactiv
arthriti
paediatr
autoimmun
neuropsychiatr
disord
associ
streptococcu
pyogen
accord
least
million
peopl
rheumat
hearth
diseas
rhd
death
annual
directli
attribut
arf
due
limit
report
relat
limit
resourc
develop
countri
like
preval
incid
arf
larg
underestim
preval
rhd
children
age
year
higher
subsaharan
africa
per
indigen
popul
australia
new
zealand
per
southcentr
asia
per
lower
develop
countri
usual
per
systemat
review
populationbas
studi
countri
contin
except
africa
publish
describ
worldwid
incid
arf
overal
mean
incid
rate
first
attack
arf
popul
mean
ci
low
incid
rate
per
year
found
america
western
europ
higher
incid
document
eastern
europ
middl
east
highest
asia
australasia
studi
longitudin
data
display
fall
incid
rate
time
unit
state
number
arf
case
fallen
dramat
last
half
centuri
nation
studi
conduct
detail
characterist
american
pediatr
patient
hospit
arf
found
incid
case
per
hospit
children
though
true
nation
incid
arf
case
case
per
popul
diagnosi
gabh
pharyng
done
throat
cultur
rapid
diagnost
test
gabh
radt
cultur
gold
standard
diagnosi
requir
hour
incub
caus
delay
identif
gabh
delay
diagnosi
often
lead
physician
administ
therapi
without
first
know
etiolog
agent
caus
overus
antibiot
provok
rise
diffus
drugresist
bacteri
strain
radt
allow
identif
gabh
throat
swab
matter
minut
strategi
signific
impact
reduc
antibiot
prescript
test
base
nitrou
acid
extract
group
carbohydr
antigen
organ
obtain
throat
swab
specif
radt
gener
high
sensit
vari
consider
rapid
test
offer
good
accuraci
use
diagnost
method
howev
situat
complement
microbiolog
cultur
possibl
fals
neg
result
tanz
et
al
studi
includ
children
year
evalu
acut
pharyng
commun
pediatr
offic
demonstr
rapid
antigendetect
test
sensit
offic
cultur
sensit
significantli
greater
rapid
antigendetect
test
specif
offic
cultur
specif
differ
statist
signific
joint
agreement
clinic
manag
pharyngotonsil
expert
recommend
guidelin
differ
consider
regard
make
diagnosi
weather
treat
mani
opinion
summar
two
posit
one
posit
espous
american
french
finnish
expert
consid
gabh
pharyng
infect
need
recognis
treat
avoid
complic
first
arf
impli
recommend
perform
microbiolog
test
detect
bacteri
form
order
treat
accord
posit
itali
region
guidelin
develop
emilia
romagna
posit
follow
uk
scottish
dutch
belgian
author
consid
pharyng
even
gabh
one
benign
self
limit
diseas
given
low
incid
suppur
complic
arf
develop
countri
second
idea
lead
reserv
antibiot
treatment
select
case
make
judici
use
antibiot
order
avoid
spread
resist
strain
accord
posit
big
retrospect
cohort
studi
conduc
petersen
et
al
uk
primari
care
practic
total
number
million
episod
respiratori
tract
infect
found
number
patient
need
treat
prevent
one
complic
upper
respiratori
tract
infect
includ
sore
throat
otiti
media
studi
conclud
antibiot
justifi
reduc
risk
seriou
complic
upper
respiratori
tract
infect
sore
throat
otiti
media
go
examin
differ
perspect
manag
pharyng
order
analyz
substanti
differ
regard
diagnosi
major
disput
concern
use
microbiolog
test
throat
cultur
radt
clinic
score
propos
centor
subsequ
modifi
consid
combin
sign
symptom
suggest
gabh
pharyng
could
help
clinician
address
diagnosi
tabl
show
centor
score
anyway
clinic
gabh
viral
pharyng
overlap
singl
element
patient
histori
physic
examin
reliabl
confirm
exclud
gabh
pharyng
indic
make
diagnosi
use
centor
score
alon
associ
microbiolog
test
vari
wide
world
english
expert
nice
guidelin
state
depend
clinic
assess
sever
patient
present
acut
pharyng
consid
immedi
antibiot
prescrib
strategi
addit
antibiot
delay
antibiot
prescrib
strategi
three
centor
criteria
present
otherwis
centor
investig
treatment
requir
uk
guidelin
reserv
immedi
antibiot
prescript
investig
situat
patient
system
unwel
symptom
sign
suggest
seriou
ill
suppur
complic
preexist
comorbid
signific
heart
lung
renal
liver
neuromuscular
diseas
immunosuppress
cystic
fibrosi
young
children
born
prematur
present
figur
show
flow
chart
uk
guidelin
nice
guidelin
equal
scottish
author
suggest
neither
throat
swab
rapid
antigen
test
carri
routin
sore
throat
even
clinic
examin
consid
reliabl
upon
differenti
viral
bacteri
etiolog
scottish
expert
consid
prevent
suppur
complic
arf
specif
indic
antibiot
therapi
pharyng
hand
american
author
suggest
necess
microbiolog
confirm
diagnosi
gabh
clinic
criteria
help
clinician
select
patient
need
test
bisno
et
al
infecti
diseas
societi
america
idsa
guidelin
state
identifi
patient
may
gabh
pharyng
consid
clinic
epidemiolog
featur
clinic
epidemiolog
featur
suggest
possibl
gabh
infect
laboratori
test
cultur
radt
perform
case
posit
antibacteri
treatment
prescrib
patient
figur
show
flow
chart
recommend
bisno
et
al
idsa
guidelin
snow
et
al
american
colleg
physician
acp
guidelin
suggest
use
centor
score
identifi
patient
may
gabh
pharyng
centor
score
microbiolog
test
perform
adult
patient
centor
score
treat
without
need
microbiolog
confirm
flow
chart
suggest
snow
et
al
acp
guidelin
illustr
figur
howev
argu
latter
approach
would
result
overtreat
sinc
patient
centor
score
suffer
streptococc
pharyng
gerber
et
al
scientif
statement
american
heart
associ
suggest
screen
patient
clinic
epidemiolog
criteria
perform
radt
throat
cultur
patient
risk
focus
pediatr
american
academi
pediatr
recommend
obtain
laboratori
confirm
presenc
gabh
decis
obtain
throat
swab
specimen
clinician
consid
age
year
clinic
sign
symptom
pharyng
season
commun
epidemiolog
includ
contact
gabh
infect
presenc
famili
person
histori
arf
poststreptococc
glomerulonephr
children
sign
symptom
suggest
viral
infect
coryza
conjunct
hoars
cough
stomat
diarrhea
test
regard
need
confirm
radt
neg
result
snow
bisno
suggest
perform
throat
cultur
children
investig
indic
adult
revers
gerber
et
al
state
radt
neg
throat
cultur
perform
adult
children
need
confirm
neg
radt
result
throat
cultur
advis
also
american
academi
pediatr
contrari
high
specif
necessari
confirm
posit
radt
test
report
radt
underus
compar
indic
given
american
guidelin
big
retrospect
usa
studi
conduct
linder
et
al
includ
total
number
children
pharyng
age
year
show
physician
perform
gabh
test
children
sore
throat
prescrib
antibiot
children
exceed
maximum
expect
preval
gabh
signific
differ
antibiot
prescript
children
gabh
test
perform
gabh
test
associ
lower
rate
antibiot
prescrib
consid
itali
region
guidelin
emilia
romagna
suggest
perform
radt
centor
score
radt
posit
antibiot
treatment
start
radt
neg
clinic
suspicion
gabh
pharyng
high
throat
cultur
perform
centor
score
physician
decid
start
treatment
directli
perform
microbiolog
test
flow
chart
illustr
figur
explain
antibiot
treatment
routin
recommend
due
preval
viral
etiolog
pharyng
howev
antimicrobi
treatment
indic
import
choos
good
therapeut
option
author
nation
guidelin
agre
suggest
penicillin
first
choic
treatment
sinc
gabh
remain
univers
suscept
penicillin
figur
acp
guidelin
flowchart
manag
pharyng
although
penicillin
v
drug
choic
ampicillin
amoxicillin
equal
effect
due
good
tast
repres
suitabl
option
children
moreov
rememb
penicillin
suspens
commerci
avail
sever
countri
includ
itali
amoxicillin
usual
prescrib
gerber
et
al
state
prompt
administr
penicillin
therapi
shorten
clinic
cours
decreas
incid
suppur
sequela
risk
transmiss
prevent
arf
even
given
day
ill
onset
therapeut
option
dose
durat
recommend
american
academi
pediatr
illustr
tabl
import
rememb
macrolid
indic
treatment
pharyng
due
high
rate
resist
erythromycin
among
gabh
usa
europ
indic
use
macrolid
pharyng
releg
patient
allerg
antibiot
allergi
prove
laboratori
test
patient
hypersensit
penicillin
type
cephalosporin
consid
good
therapeut
option
indic
use
amoxicillin
daili
propos
gerber
et
al
wide
employ
usa
univers
accept
amoxicillin
given
daili
approv
food
drug
administr
fda
european
medicin
agenc
emea
primari
profylaxi
arf
standard
durat
antibiot
therapi
day
propos
shorten
day
improv
complianc
cochran
review
studi
involv
total
number
case
acut
gabh
publish
author
compar
short
durat
therapi
three
six
day
oral
antibiot
type
includ
standard
durat
treatment
found
short
durat
treatment
present
lower
risk
earli
clinic
treatment
failur
signific
differ
earli
bacteriolog
treatment
failur
late
clinic
recurr
anyway
overal
risk
late
bacteriolog
recurr
wors
short
durat
treatment
although
signific
differ
found
studi
employ
low
dose
azithromycin
mgkg
elimin
author
conclud
short
cours
day
oral
antibiot
efficaci
compar
standard
durat
therapi
treat
children
acut
gabh
pharyng
nevertheless
result
review
larg
critic
shad
underlin
least
one
elig
trial
one
metaanalysi
includ
besid
trial
includ
methodolog
inaccuraci
ie
random
describ
inappropri
major
studi
blind
moreov
arf
consid
main
outcom
includ
studi
total
event
record
insuffici
power
make
conclus
fagala
et
al
recent
metaanalysi
random
trial
rct
patient
found
shortcours
treatment
gabh
pharyngotonsil
associ
inferior
bacteriolog
erad
rate
adequ
therapi
followup
cultur
necessari
unless
symptom
recur
recurr
pharyng
may
repres
relaps
may
result
new
exposur
case
relaps
cephalosporin
propos
effect
penicillin
author
suggest
cephalosporin
could
efficaci
higher
penicillin
gabh
pharyng
metaanalysi
rct
involv
adult
patient
gabh
pharyng
casey
pichichero
indic
likelihood
bacteriolog
clinic
cure
gabh
tonsillopharyng
adult
significantli
higher
day
therapi
oral
cephalosporin
oral
penicillin
report
absolut
differ
bacteriolog
failur
rate
cephalosporin
penicillin
also
conduct
metaanalysi
rct
cephalosporin
versu
penicillin
treatment
gabh
pharyng
children
indic
likelihood
bacteriolog
clinic
failur
significantli
less
oral
cephalosporin
prescrib
compar
oral
penicillin
anyway
must
rememb
guidelin
recommend
cephalosporin
first
choic
drug
treatment
gabh
pharyng
higher
cost
compar
penicillin
risk
select
resist
strain
recommend
guidelin
limit
patient
hypersens
non
type
correct
diagnosi
treatment
gabh
pharyng
key
point
attain
judici
use
antibiot
figur
emilia
romagna
region
guidelin
flowchart
manag
pharyng
prevent
suppur
non
suppur
sequela
thu
prudenti
believ
paediatrician
perform
least
one
microbiolog
test
radt
throat
coltur
pharyng
suspect
gabh
etiolog
order
make
correct
diagnosi
radt
provid
result
minut
sensit
gener
high
practic
suggest
neg
radt
confirm
throat
cultur
clinic
suspicion
gabh
pharyng
high
pharyng
prove
bacteri
etiolog
receiv
antibiot
treatment
penicillin
v
first
choic
drug
oral
suspens
avail
itali
amoxicillin
equal
effect
demonstr
higher
palat
use
first
line
therapi
macrolid
indic
treatment
gabh
pharyng
except
patient
prove
allergi
penicillin
laboratori
confirm
requir
group
patient
cephalosporin
repres
good
altern
left
case
type
hypersensit
penicillin
inappropri
use
macrolid
treatment
gabh
pharyng
main
caus
resist
strain
diffus
western
countri
import
underlin
treatment
durat
day
improv
patient
complianc
physician
explain
import
complet
treatment
day
erad
bacterium
even
clinic
improv
occur
first
day
treatment
date
italian
guidelin
avail
believ
fundament
establish
ration
uniform
approach
manag
acut
gabh
pharyng
countri
